Extending life beyond current limits vs. an emphasis on preserving a healthy life presents a pressing question: Death may be a problem to be conquered, but to what end?
Image courtesy by QUE.com The landscape of healthcare is undergoing a seismic shift. We are moving away from a reactive model ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...
Objectives Enteral nutrition (EN) constitutes a critical therapeutic intervention in the management of patients with sepsis; however, the optimal timing for its initiation remains uncertain. This ...
The American biotechnology company Life Biosciences announced last week that it has administered the first experimental treatment ER-100 to a patient suffering from glaucoma, one of the main causes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results